US Stock MarketDetailed Quotes

HALO Halozyme Therapeutics

Watchlist
  • 48.030
  • +0.490+1.03%
Close Dec 26 16:00 ET
  • 48.310
  • +0.280+0.58%
Post 19:04 ET
6.11BMarket Cap15.90P/E (TTM)

Halozyme Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Business Currency:USD
2024/Q3
Stock NameRevenueRatio
Royalties155.06M53.45%
Product sales, net86.66M29.87%
Revenues Under Collaborative Agreements48.36M16.67%
Region Currency:USD
2023/FY
Stock NameRevenueRatio
United States587.2M70.81%
Switzerland149.02M17.97%
Belgium58.35M7.04%
All Other Foreign19.58M2.36%
Japan15.1M1.82%
Heat List
US
Overall
Symbol
Price
% Chg

No Data